Objective To assist policymakers as they reflect on treatment protocols and approaches for
the efficient delivery of medical care for multiple sclerosis (MS) patients in Japan. Methods …

Introduction The healthcare situation of multiple sclerosis (MS) and its course are not being
thoroughly investigated in Japan. We aimed to examine the current healthcare situation …

Objective To understand, through an analysis of health insurance claims data, the current
treatment status and medical cost of multiple sclerosis (MS) in Japan. Methods We analyzed …

Background In this study, we aimed to understand the trends in total and itemized medical
expenses, especially of disease-modifying therapy (DMT), for multiple sclerosis (MS) in …

Background Administrative healthcare claims data provide a mechanism for assessing and
monitoring multiple sclerosis (MS) disease status across large, clinically representative “real …

Background Medical therapy for multiple sclerosis (MS) is expensive. Quantifying the burden
of MS is fundamental for health-care planning and the allocation of resources for the …

Objective: Administrative claims databases provide a wealth of data for assessing the effect
of treatments in clinical practice. Our aim was to propose methodology for real-world studies …

BACKGROUND: Multiple sclerosis (MS) is chronic and debilitating, afflicts patients in the
prime of their lives, and requires costly, decades-long disease management. MS prevalence …

Background Estimating direct healthcare costs of patients with multiple sclerosis (MS) and
identifying risk factors of high costs including relapse are important drivers of public health …

Background For patients with multiple sclerosis (MS), previous research identified key
disease sequelae as important cost drivers and suggested that among users of disease …